文献速递青光眼眼外伤

虹膜微血管瘤病:14例连续患者的临床、荧光血管造影与OCT血管成像特征

Iris Microhemangiomatosis: Clinical, Fluorescein Angiography, and Optical Coherence Tomography Angiography Features in 14 Consecutive Patients.
PubMed 文献 · Am J Ophthalmol · 2018-08-15

病变表现为瞳孔缘多灶性扩张血管通道,可伴视力下降、前房积血和青光眼;AS-IVFA可确诊,仅9%患眼需激光光凝。

要点

  • 虹膜微血管瘤病常表现为自发性单眼前房积血和/或继发性青光眼。
  • AS-IVFA可显示瞳孔缘血管病变伴轻度染色,有助于确诊。
  • 多数患眼建议观察,仅反复前房积血者需氩激光光凝。

核心结论

  • 虹膜微血管瘤病是一种罕见眼部疾病,常表现为自发性单眼前房积血和/或继发性青光眼。
  • AS-IVFA可确认诊断,仅9%患眼需要激光光凝干预。

研究设计与样本

  • 所有患者均行临床检查和裂隙灯摄影,条件允许时行AS-OCT、AS-OCTA、AS-IVFA和超声生物显微镜检查。

主要发现

  • 患者平均年龄70岁(范围58-82岁),全部为白人。
  • 虹膜血管瘤表现为瞳孔缘环周排列的细微多灶性扩张血管通道。
  • 虹膜颜色为蓝色(19眼)或绿色(3眼),病变单侧6例、双侧8例。
  • 其他特征包括视力下降(13眼)、前房积血(12眼)和青光眼(7眼)。
  • 无眼外伤史或全身血管病变情况。

关键数值与推荐

  • AS-OCT记录瞳孔缘细微簇状病变,AS-OCTA显示血管流,AS-IVFA显示瞳孔缘血管病变伴轻度染色。
  • 20例(91%)建议观察,2例(9%)因反复前房积血行氩激光光凝。

临床怎么用

  • 对自发性单眼前房积血和/或继发性青光眼患者应怀疑虹膜微血管瘤病。
  • AS-IVFA可用于确认诊断。
  • 多数患者可观察,反复前房积血者可考虑氩激光光凝。

局限性

  • 单中心研究,全部患者为白人。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To describe the clinical and imaging findings and treatment options in a series of patients with iris microhemangiomatosis. DESIGN: Retrospective observational case series. METHODS: Setting: Single institution. STUDY POPULATION: Twenty-two eyes of 14 consecutive patients with iris microhemangiomatosis were reviewed. OBSERVATION PROCEDURES: Clinical examination and slit-lamp photography were performed on every patient. Anterior segment optical coherence tomography (AS-OCT), anterior segment optical coherence tomography angiography (AS-OCTA), anterior segment intravenous fluorescein angiography (AS-IVFA), and ultrasound biomicroscopy were performed when possible. MAIN OUTCOME MEASURES: Clinical and imaging features and treatment strategies. RESULTS: Twenty-two eyes of 14 patients with iris microhemangiomatosis were included in this series. Mean patient age was 70 years (range, 58-82 years), and all patients were white. The iris hemangiomatosis appeared as subtle, multifocal, ectatic vascular channels arranged circumferentially at the pupillary margin. Iris color was blue (n = 19 eyes) or green (n = 3 eyes), and the features were unilateral (n = 6 patients) or bilateral (n = 8 patients). Additional features included reduced visual acuity (n = 13 eyes), hyphema (n = 12 eyes), and glaucoma (n = 7 eyes). There was no history of ocular trauma or systemic vasculopathic conditions. AS-OCT documented the fine tuft at the pupillary margin, AS-OCTA showed vascular flow, and AS-IVFA demonstrated pupillary margin vascular lesions with mild staining. Observation was advised in 20 cases (91%), and argon laser photocoagulation was required for repetitive hyphema in 2 cases (9%). CONCLUSION: Iris microhemangiomatosis is a rare ocular condition, often manifesting with spontaneous unilateral hyphema and/or secondary glaucoma. AS-IVFA confirms the diagnosis, and intervention with laser photocoagulation is necessary in only 9% of eyes.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Williams BK, Di Nicola M, Ferenczy S, et al. Iris Microhemangiomatosis: Clinical, Fluorescein Angiography, and Optical Coherence Tomography Angiography Features in 14 Consecutive Patients. Am J Ophthalmol. 2018. PMID: 30118687. doi:10.1016/j.ajo.2018.08.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。